OBJECTIVE: To evaluate the impact of the interaction of physical function and emotional well-being on disease-related parameters and coping with rheumatoid arthritis. METHODS: A cross-sectional survey among 177 RA patients included demographic and disease-related variables as well as the following patient-reported outcome measures: Health Assessment Questionnaire-Disability Index (HAQ-DI) (physical function), Mental Component Summary Scale of the SF-36 (MCSS) for emotional well-being, Rheumatoid Arthritis Disease Activity Index (RADAI), and Coping with Rheumatoid Arthritis Questionnaire (C-RAQ). Based on HAQ-DI and MCSS, six categories representing various levels of physical and emotional impairment were formed. Multivariate analysis of variance and a subsequent discriminant analysis were used to evaluate whether demographic and disease-related variables and coping strategies differed between these categories. RESULTS: Patients with moderate to high impairment of physical function and emotional well-being reported significantly higher disease activity and a more frequent use of distancing and active problem solving coping strategies than patients with low-level impairment (p<0.001-0.043). Furthermore, these patients reported experiencing significantly higher levels of helplessness (p<0.001-0.032). Results from the discriminant analysis highlighted a combination of disease activity and helplessness to differentiate best between patients with either low or high impairment of physical function and emotional well-being (p<0.001). CONCLUSION: Aside from perceived disease activity, helplessness, and distancing as well as active problem solving allowed for a good discrimination between the different levels of impairment of physical function and emotional well-being. Encouraging and educating patients on how to cognitively reframe their current situation might play a key role in reducing the level of helplessness resulting from impairments of physical function and emotional well-being.
OBJECTIVE: To evaluate the impact of the interaction of physical function and emotional well-being on disease-related parameters and coping with rheumatoid arthritis. METHODS: A cross-sectional survey among 177 RApatients included demographic and disease-related variables as well as the following patient-reported outcome measures: Health Assessment Questionnaire-Disability Index (HAQ-DI) (physical function), Mental Component Summary Scale of the SF-36 (MCSS) for emotional well-being, Rheumatoid Arthritis Disease Activity Index (RADAI), and Coping with Rheumatoid Arthritis Questionnaire (C-RAQ). Based on HAQ-DI and MCSS, six categories representing various levels of physical and emotional impairment were formed. Multivariate analysis of variance and a subsequent discriminant analysis were used to evaluate whether demographic and disease-related variables and coping strategies differed between these categories. RESULTS:Patients with moderate to high impairment of physical function and emotional well-being reported significantly higher disease activity and a more frequent use of distancing and active problem solving coping strategies than patients with low-level impairment (p<0.001-0.043). Furthermore, these patients reported experiencing significantly higher levels of helplessness (p<0.001-0.032). Results from the discriminant analysis highlighted a combination of disease activity and helplessness to differentiate best between patients with either low or high impairment of physical function and emotional well-being (p<0.001). CONCLUSION: Aside from perceived disease activity, helplessness, and distancing as well as active problem solving allowed for a good discrimination between the different levels of impairment of physical function and emotional well-being. Encouraging and educating patients on how to cognitively reframe their current situation might play a key role in reducing the level of helplessness resulting from impairments of physical function and emotional well-being.
Authors: Ingris Peláez-Ballestas; Annelis Boonen; Janitzia Vázquez-Mellado; Isabel Reyes-Lagunes; Adolfo Hernández-Garduño; Maria Victoria Goycochea; Ana G Bernard-Medina; Jacqueline Rodríguez-Amado; Julio Casasola-Vargas; Mario A Garza-Elizondo; Francisco J Aceves; Clara Shumski; Ruben Burgos-Vargas Journal: Medicine (Baltimore) Date: 2015-03 Impact factor: 1.889
Authors: Margot J M Walter; Adriaan Van't Spijker; Annelieke Pasma; Johanna M W Hazes; Jolanda J Luime Journal: Qual Life Res Date: 2016-07-21 Impact factor: 4.147
Authors: Maaike Ferwerda; Sylvia van Beugen; Henriët van Middendorp; Henk Visser; Harald Vonkeman; Marjonne Creemers; Piet van Riel; Wietske Kievit; Andrea Evers Journal: J Med Internet Res Date: 2018-10-11 Impact factor: 5.428
Authors: H M Schenker; K Tascilar; L Konerth; M Sergeeva; J Prade; S Strobelt; A Kleyer; D Simon; L Mendez; M Hagen; V Schönau; A Hueber; J Roesch; A Dörfler; A Hess; G Schett; J Rech Journal: Contemp Clin Trials Commun Date: 2021-05-04